Study of circulating IgG antibodies to BIRC5 and MYC in non‐small cell lung cancer

E-ISSN： 2211-5463|5|1|809-812

ISSN： 2211-5463

Source： FEBS Open Bio, Vol.5, Iss.1, 2015-01, pp. : 809-812

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Study of circulating IgG antibodies to peptide antigens derived from BIRC5 and MYC in cervical cancer

FEBS Open Bio, Vol. 5, Iss. 1, 2015-01 ,pp. : 198-201

John Wiley & Sons Inc

Access to resources Recommend Favorite

Further study of circulating IgG antibodies to CD25‐derived peptide antigens in nonsmall cell lung cancer

FEBS Open Bio, Vol. 6, Iss. 3, 2016-02 ,pp. : 211-215

John Wiley & Sons Inc

Access to resources Recommend Favorite

Arf6, RalA, and BIRC5 protein expression in nonsmall cell lung cancer

By Knizhnik A. Kovaleva O. Laktionov K. Mochalnikova V. Komelkov A. Tchevkina E. Zborovskaya I.

Molecular Biology, Vol. 45, Iss. 2, 2011-04 ,pp. : 275-282

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite

The development of immunotherapies for non-small cell lung cancer

By Salgaller Michael L

Expert Opinion on Biological Therapy, Vol. 2, Iss. 3, 2002-03 ,pp. : 265-278

Informa Healthcare

Access to resources Recommend Favorite

Cetuximab in non-small cell lung cancer

By Ademuyiwa Foluso O Hanna Nasser

Expert Opinion on Biological Therapy, Vol. 8, Iss. 1, 2008-01 ,pp. : 107-113

Informa Healthcare

Access to resources Recommend Favorite